Ethiopia to Seek Potential Investments from Chinese Pharma Companies


Published Date : Oct 27, 2015

A group of ten Chinese pharmaceutical companies visited Ethiopia to find out the feasibility of investment in the medical industry. A delegation of ten leading pharmaceutical companies of China visited Ethiopia on 20th October 2015 with an intention to partnership with some of the emerging Ethiopia medical supplies companies to manufacture drugs. The plan includes manufacturing drugs for cancer and for many other health problems. The initiative also includes the transfer of technology and knowledge to the emerging medical supplies companies in Ethiopia. The delegation met top government officials of Ethiopia along with Arkebe Oqubay, the Prime Minister’s Adviser. The arrangement was brokered between UNAIDS China and the China Chamber of Commerce for Import and Export of Medicines and Health Products.

The delegates of ten leading Chinese medical supplies companies visited many industrial parks in Ethiopia including the Eastern Industrial Zone at Dukem and the project at Kilinto. Julphar, the pharmaceutical company based in the U.A.E has its operations in Ethiopia. The delegates also visited Julphar’s office in Ethiopia. Xu Ming, the vice president of the China Chamber of Commerce for Import and Export of Medicines and Health Products and the head of the delegation said that the visit was primarily planned to determine the possibility of developing manufacturing plants for drugs and medical equipment in several regions in Ethiopia. 

The Chinese pharmaceutical companies are planning to invest in Ethiopia in 3 phases. In the first phase, the companies will manufacture basic drugs. In the second phase, the companies will focus on manufacturing a wide variety of drugs meant for cancer and other health issues. Knowledge transfer activities will be planned by the Chinese companies for the Ethiopian counterparts in the third phase. Currently, Ethiopia is in need of even the basic medical supplies. The visit of the Chinese delegation to Ethiopia is expected to change the situation of the medical device sector and pharmaceutical industry in the Ethiopian and African region.